Renephra secures investment from Deepbridge Capital and Catapult Ventures
Renephra, a medical device company, has raised GBP231,000 from Deepbridge Capital and the GM&C Life Sciences Fund, managed by Catapult Ventures. Renephra, spun out of The University of Manchester and Manchester University NHS Foundation Trust by UMI3 Ltd, is developing an innovative medical device to treat patients with chronic oedema